AI eye test could save your sight
NCT ID NCT07069647
First seen Nov 19, 2025 · Last updated May 21, 2026 · Updated 20 times
Summary
This study tests whether using an AI tool (VeriSee) to screen for diabetic retinopathy and age-related macular degeneration in regular doctor visits can catch these eye diseases earlier than standard exams. About 4,300 adults with diabetes or aged 50+ will be randomly assigned to AI-assisted screening or usual care. The goal is to see if AI helps more people get timely treatment and reduces vision loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY, DR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Taiwan University Hospital
RECRUITINGTaipei, 100225, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.